SCHEMBL7369619

SCHEMBL7369619

O=Cc1ccc(COCc2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.62
ALDH1A1 P00352 3/20 0.52
CYP2A6 P11509 1/20 0.52
MAOA P21397 4/20 0.51
MAOB P27338 4/20 0.51
RAB9A P51151 1/20 0.49
ALDH5A1 P51649 1/20 0.43
ABAT P80404 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
IDO1 P14902 1/20 0.41
CA12 O43570 1/20 0.41
AKR1B10 O60218 1/20 0.41
AKR1B1 P15121 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4173773 0.87 TSHR (0.47) TSHRALDH1A1CYP2A6MAOAMAOB
SCHEMBL1728331 0.84 TDP1 (0.54) TSHRMAOAMAOBRAB9AIDO1
SCHEMBL1662921 0.84 TSHR (0.58) TSHRALDH1A1CYP2A6MAOAMAOB
SCHEMBL12933615 0.83 ALDH5A1 (0.46) ALDH1A1CYP2A6MAOAMAOBRAB9A
SCHEMBL31568503 0.82 MAOA (0.65) TSHRALDH1A1CYP2A6MAOAMAOB
SCHEMBL865349 0.82 RAB9A (0.71) TSHRALDH1A1MAOAMAOBRAB9A
SCHEMBL6522331 0.82 MAOA (0.65) TSHRALDH1A1CYP2A6MAOAMAOB
SCHEMBL2222928 0.82 ALDH1A1 (0.62) ALDH1A1CYP2A6MAOAMAOBRAB9A
SCHEMBL6606455 0.82 ALOX5 (0.54) TSHRALDH1A1CYP2A6MAOAMAOB
SCHEMBL6606457 0.82 ALOX5 (0.54) TSHRALDH1A1CYP2A6MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240425513-A1 OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28 CARMOT THERAPEUTICS, INC. 2024-12-26 US disclosed
EP-4419508-A2 OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28 Carmot Therapeutics, Inc. (US) 2024-08-28 EP disclosed
WO-2023069721-A2 OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28 CARMOT THERAPEUTICS, INC. (US) 2023-04-27 WO disclosed
WO-2023069721-A2 OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28 CARMOT THERAPEUTICS, INC. (US) 2023-04-27 WO disclosed
US-5952321-A Substituted azetidinones as anti-inflammatory and antidegenerative agents MERCK & CO., INC. (US) 1999-09-14 US disclosed
EP-0666846-A4 1995-09-20 EP disclosed
EP-0666846-A1 NEW SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS MERCK & CO. INC. (US) 1995-08-16 EP disclosed
WO-1994010143-A1 NEW SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS MERCK & CO., INC. (US) 1994-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240425513-A1 OXAZOLE, OXADIAZOLE, AND INDOLE DERIVATIVES FOR THE INHIBITION OF USP28 USP28, USP25, USP39 TSHR 3475/4885ALDH1A1 942/4885CYP2A6 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.